What is the recommended management for a patient taking fluvoxamine 100 mg who has adequate control of obsessive‑compulsive disorder but persistent depression and anxiety?

Increase Fluvoxamine Dose First, Then Consider Augmentation

For a patient with OCD controlled on fluvoxamine 100mg but persistent depression and anxiety, the most appropriate next step is to increase the fluvoxamine dose up to 300mg daily, as the current dose is suboptimal and higher doses are often required for full therapeutic benefit across the anxiety-depression spectrum 1.

Rationale for Dose Optimization

The FDA-approved dosing for fluvoxamine starts at 50mg and can be titrated up to 300mg daily for OCD 1. Your patient is only at 100mg—the lower end of the therapeutic range. The evidence strongly supports that:

• Fluvoxamine demonstrates efficacy across the anxiety-depressive spectrum, including generalized anxiety disorder, social anxiety disorder, and depression, not just OCD 2, 3, 4
• Higher doses (100-300mg) are typically needed for optimal response 1, 2
• The drug should be titrated in 50mg increments every 4-7 days as tolerated 1

Specific Dosing Algorithm

1. Increase to 150mg daily (give as single bedtime dose or split with larger dose at bedtime)
2. Wait 1-2 weeks and reassess symptoms
3. If partial response, increase to 200mg daily (split into two divided doses with larger dose at bedtime)
4. Wait another 1-2 weeks and reassess
5. If still inadequate, increase to 250-300mg daily (split doses, larger at bedtime)
6. Allow 8-12 weeks at maximum tolerated dose before declaring treatment failure 5, 1

Important Prescribing Considerations

Monitor for drug interactions carefully as fluvoxamine is a potent inhibitor of CYP1A2, CYP2C19, CYP2C9, and CYP3A4 6. This is particularly important if the patient takes:

• Benzodiazepines (especially alprazolam, midazolam, triazolam)—reduce benzodiazepine dose by 50% 1
• Other medications metabolized by these enzymes

Common side effects to discuss: nausea (most common), somnolence, headache, and potential for discontinuation syndrome if abruptly stopped 6, 2.

If Dose Optimization Fails

Only after achieving 8-12 weeks at the maximum tolerated dose (ideally 250-300mg) should you consider:

1. Adding CBT if not already implemented—combination therapy shows superior outcomes for anxiety disorders 6
2. Augmentation with another agent:
   • For persistent OCD symptoms: consider antipsychotic augmentation (risperidone or aripiprazole) 5
   • For depression/anxiety: consider switching to a different SSRI with better depression efficacy (escitalopram, sertraline) 7, 8
   • Avoid combining with another serotonergic agent without extreme caution due to serotonin syndrome risk 6

Critical Pitfall to Avoid

Do not prematurely switch or augment before optimizing the fluvoxamine dose. The evidence shows that many patients require doses of 200-300mg for full therapeutic benefit 1, 9, 2, and one case report even demonstrated remission at 600mg (though this exceeds FDA recommendations) 9. Your patient at 100mg has not yet received an adequate trial.